Banco Bilbao Vizcaya Argentaria, S.A. Heron Therapeutics, Inc. Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $9.82 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
182Shares Held
125MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$53.2 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$16.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$16.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$15.6 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.9 Million26.51% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $236M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...